APA

Imamura M., Nishimukai A., Higuchi T., Ozawa H., Yanai A., Miyagawa Y., Murase K., Sakita I., Hatada T., Takatsuka Y., Katagiri T. & Miyoshi Y. (20160906). High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients. : Breast cancer research and treatment.

Chicago

Imamura Michiko, Nishimukai Arisa, Higuchi Tomoko, Ozawa Hiromi, Yanai Ayako, Miyagawa Yoshimasa, Murase Keiko, Sakita Isao, Hatada Takuya, Takatsuka Yuichi, Katagiri Toyomasa and Miyoshi Yasuo. 20160906. High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients. : Breast cancer research and treatment.

Harvard

Imamura M., Nishimukai A., Higuchi T., Ozawa H., Yanai A., Miyagawa Y., Murase K., Sakita I., Hatada T., Takatsuka Y., Katagiri T. and Miyoshi Y. (20160906). High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients. : Breast cancer research and treatment.

MLA

Imamura Michiko, Nishimukai Arisa, Higuchi Tomoko, Ozawa Hiromi, Yanai Ayako, Miyagawa Yoshimasa, Murase Keiko, Sakita Isao, Hatada Takuya, Takatsuka Yuichi, Katagiri Toyomasa and Miyoshi Yasuo. High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients. : Breast cancer research and treatment. 20160906.